SharesGrow.com Intrinsic Value of S&P & Nasdaq Contact Us

हिन्दी

← Back to all stocks

Alfresa Holdings Corporation ARHCF OTC

Other OTC • Healthcare • Medical - Distribution • JP • USD

SharesGrow Score

SharesGrow Intrinsic Value

Negative cash flow

Alfresa Holdings Corporation (ARHCF) is a Medical - Distribution company in the Healthcare sector, currently trading at $11.87. It has a SharesGrow Score of 62/100, indicating a above average investment profile with 3 out of 7 criteria passed.

Financials: revenue is $3.0T, +4.6%/yr average growth. Net income is $27.4B, growing at -4.2%/yr. Net profit margin is 0.9% (thin). Gross margin is 7.2% (-0.1 pp trend).

Balance sheet: total debt is $35.5B against $481.8B equity (Debt-to-Equity (D/E) ratio 0.07, conservative). Current ratio is 1.22 (adequate). Debt-to-assets is 2.5%. Total assets: $1.4T.

SharesGrow 7-Criteria breakdown: Value 100/100 (Pass), Growth 30/100 (Fail), Past 100/100 (Pass), Health 83/100 (Pass), Moat 43/100 (Fail), Future ?/100 (Fail), Income 30/100 (Fail).

ARHCF SharesGrow Score Overview

64/100

SharesGrow Score

Above average fundamentals

View full scorecard →

VALUE 100/100

Valuation — P/E, PEG, Forward PEG

GROWTH 30/100

Financials — average growth

PAST 100/100

strong — trend

HEALTH 83/100

Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is

MOAT 43/100

Gross margin is + market cap

FUTURE 0/100

Analyst outlook — as buy

INCOME 30/100

Net profit margin is

Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — ARHCF

ARHCF trades at a trailing Price-to-Earnings (P/E) of N/A (S&P 500 average ~25). Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.

View details →

ARHCF: +4.6%/yr revenue is, -4.2%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.

View details →

ARHCF: 4 / 4 years profitable. strong — 100%. Score = 4 / 4 × 100. ≥ 80 = Pass.

View details →

Balance sheet ARHCF: Debt-to-Equity (D/E) ratio 0.07 (conservative), Current ratio is 1.22 (adequate). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.

View details →

ARHCF: Gross margin is 7.2% (-0.1 pp trend), $2B market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 43/100. ≥ 70 = Pass.

View details →

No analyst coverage available for this stock.

ARHCF: Net profit margin is 0.9%. thin (0-5%). Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.

View details →

Stock Chart & Stats

Market Data

52-Week Range11.87-11.87

Volume1K

Avg Volume (30D)412

Market Cap$2.16B

Beta (1Y)-0.12

Dividend Yield$0.4633

Share Statistics

EPS (TTM)147.54

Shares Outstanding$185.64M

IPO Date2020-06-08

Employees12,517

CEORyuji Arakawa

Financial Highlights & Ratios

Revenue (TTM)$2.96T

Gross Profit$213.93B

EBITDA$54.56B

Net Income$27.39B

Operating Income$38.08B

Total Cash$177.09B

Total Debt$35.55B

Net Debt$-141.54B

Total Assets$1.44T

Price / Earnings (P/E)0.1

Price / Sales (P/S)0

Analyst Forecast

Company Info

CountryJP

ExchangeOther OTC

CurrencyUSD

ISINJP3126340003

Price Chart

ARHCF

Alfresa Holdings Corporation ↗ · Other OTC

Healthcare • Medical - Distribution

People Also View

McKesson Corporation

Cardinal Health, Inc.

Henry Schein, Inc.

Patterson Companies, Inc.

Owens & Minor, Inc.

Eli Lilly and Company

Johnson & Johnson

Contact Us

🎓

SharesGrow Academy

Learn how to calculate Intrinsic Value and find undervalued stocks.

Weekly live sessions

📧 [email protected]

📞 +65 8912 8000

Send us a message